| J3245 | Injection, tildrakizumab, 1 mg | 2,000 | $110 | $220K |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 6,000 | $20 | $102K |
| J0897 | Injection, denosumab, 1 mg | 3,480 | $20 | $62.6K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 480 | $100 | $46.5K |
| J2357 | Injection, omalizumab, 5 mg | 1,490 | $30 | $44.5K |
| 99222 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 160 | $100 | $16.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 140 | $100 | $14.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 280 | $50 | $14.1K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 90 | $140 | $12.1K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 190 | $60 | $11.7K |